摘要:
The present invention relates to a method for mutation analysis of the HIV pol gene of HIV-1 virions comprising amplifying virion RNA or DNA via nested PCR using outer primers as represented in SEQ ID No. 1 and 2, amplifying said PCR product via nested PCR using a 5′ and 3′ primer chosen from the inner primers SEQ ID No. 3, 4, 5 and 6, and sequencing this secondary obtained PCR product using at least one sequencing primer chosen from any of SEQ ID No. 7 to 12 or variants thereof. In the alternative, at least one secondary sequencing primer may be used chosen from any of SEQ ID No. 13 to 24. The present invention also relates to kits for performing such a method as well as primers for performing the same.
摘要翻译:本发明涉及HIV-1病毒体的HIV pol基因的突变分析方法,其包括使用SEQ ID No.1和2所示的外部引物通过巢式PCR扩增病毒粒子RNA或DNA,通过巢式PCR扩增所述PCR产物 使用选自内部引物SEQ ID No.3,4,5和6的5'和3'引物,并使用至少一种选自SEQ ID No.7至12中的任一个的测序引物或该序列获得的PCR产物 其变体。 在替代方案中,可以使用从SEQ ID No.13至24中任一个选择的至少一个二次测序引物。本发明还涉及用于进行该方法的试剂盒以及用于进行该方法的引物。
摘要:
The present invention relates to a method of for mutation analysis of the HIV pol gene of HIV-1 virions comprising amplifying viral RNA or DNA via nested PCR using outer primers as represented in SEQ ID No: 1 and 2, amplifying said PCR product via nested PCR using a 5′ and 3′ primer chosen from the inner primers SEQ ID No: 3, 4, 5, and 6, and sequencing this secondary obtained PCR product using at least one sequencing primer chosen from any of SEQ ID No: 7 to 12 or variants thereof. In the alternative, at least one secondary sequencing primer may be used chosen from any of SEQ ID No: 13 to 24. The present invention also relates to kits for performing such a method as well as primers for performing the same.
摘要翻译:本发明涉及HIV-1病毒粒子的HIV pol基因的突变分析方法,其包括使用SEQ ID No:1和2所示的外部引物通过巢式PCR扩增病毒RNA或DNA,通过嵌套扩增所述PCR产物 使用选自内部引物SEQ ID No:3,4,5和6的5'和3'引物进行PCR,并使用至少一种选自SEQ ID No:7至 12或其变体。 在替代方案中,可以使用从SEQ ID No:13至24中任一个选择的至少一个二次测序引物。本发明还涉及用于进行该方法的试剂盒以及用于进行该方法的引物。
摘要:
The present invention relates to a method for mutation analysis of the HIV pol gene of HIV virions comprising amplifying virion RNA or DNA via nested PCR using outer primers as represented in SEQ ID No. 1 and 2, amplifying said PCR product via nested PCR using a 5′ and 3′ primer chosen from the inner primers SEQ ID No. 3, 4, 5, and 6, and sequencing this secondary obtained PCR product using at least one sequencing primer chosen from any of SEQ ID No. 7 to 12 or variants thereof. In the alternative, at least one secondary sequencing primer may be used chosen from any of SEQ ID No. 13 to 24. The benefit of the sequences present in the invention resides in the fact that, with the aid of the oligonucleotides, the sequences of all presently known HIV subtypes and all mutations of the pol gene presently known to yield resistance towards antiretroviral therapy can be determined. The present invention also relates to kits for performing such a method as well as primers for performing the same.
摘要翻译:本发明涉及HIV病毒体的HIV pol基因的突变分析方法,其包括使用SEQ ID No.1和2所示的外部引物通过巢式PCR扩增病毒体RNA或DNA,通过巢式PCR扩增所述PCR产物,使用 选自内引物SEQ ID No.3,4,5和6的5'和3'引物,并使用至少一种选自SEQ ID No.7至12或任何变体的测序引物对该次级获得的PCR产物进行测序 其中。 在替代方案中,可以使用从SEQ ID No.13至24中任一个中选择的至少一个二次测序引物。存在于本发明中的序列的益处在于:借助于寡核苷酸, 目前已知所有目前已知的HIV亚型和目前已知对抗逆转录病毒治疗产生抗性的pol基因的所有突变可以被确定。 本发明还涉及用于进行这种方法的试剂盒以及用于进行该方法的引物。
摘要:
The present invention relates to a method of for mutation analysis of the HIV pol gene of HIV-1 virions comprising amplifying viral RNA or DNA via nested PCR using outer primers as represented in SEQ ID No: 1 and 2, amplifying said PCR product via nested PCR using a 5′ and 3′ primer chosen from the inner primers SEQ ID No: 3, 4, 5, and 6, and sequencing this secondary obtained PCR product using at least one sequencing primer chosen from any of SEQ ID No: 7 to 12 or variants thereof. In the alternative, at least one secondary sequencing primer may be used chosen from any of SEQ ID No: 13 to 24. The present invention also relates to kits for performing such a method as well as primers for performing the same.
摘要翻译:本发明涉及HIV-1病毒粒子的HIV pol基因的突变分析方法,其包括使用SEQ ID No:1和2所示的外部引物通过巢式PCR扩增病毒RNA或DNA,通过嵌套扩增所述PCR产物 使用选自内部引物SEQ ID No:3,4,5和6的5'和3'引物进行PCR,并使用至少一种选自SEQ ID No:7至 12或其变体。 在替代方案中,可以使用从SEQ ID No:13至24中任一个选择的至少一个二次测序引物。本发明还涉及用于进行该方法的试剂盒以及用于进行该方法的引物。
摘要:
The present invention relates to a method for mutation analysis of the HIV pol gene of HIV virions comprising amplifying virion RNA or DNA via nested PCR using outer primers as represented in SEQ ID No. 1 and 2, amplifying said PCR product via nested PCR using a 5′ and 3′ primer chosen from the inner primers SEQ ID No. 3, 4, 5, and 6, and sequencing this secondary obtained PCR product using at least one sequencing primer chosen from any of SEQ ID No. 7 to 12 or variants thereof. In the alternative, at least one secondary sequencing primer may be used chosen from any of SEQ ID No. 13 to 24. The benefit of the sequences present in the invention resides in the fact that, with the aid of the oligonucleotides, the sequences of all presently known HIV subtypes and all mutations of the pol gene presently known to yield resistance towards antiretroviral therapy can be determined. The present invention also relates to kits for performing such a method as well as primers for performing the same.
摘要翻译:本发明涉及HIV病毒体的HIV pol基因的突变分析方法,其包括使用SEQ ID No.1和2所示的外部引物通过巢式PCR扩增病毒体RNA或DNA,通过巢式PCR扩增所述PCR产物,使用 选自内引物SEQ ID No.3,4,5和6的5'和3'引物,并使用至少一种选自SEQ ID No.7至12或任何变体的测序引物对该次级获得的PCR产物进行测序 其中。 在替代方案中,可以使用从SEQ ID No.13至24中任一个中选择的至少一个二次测序引物。存在于本发明中的序列的益处在于:借助于寡核苷酸, 目前已知所有目前已知的HIV亚型和目前已知对抗逆转录病毒治疗产生抗性的pol基因的所有突变可以被确定。 本发明还涉及用于进行这种方法的试剂盒以及用于进行该方法的引物。
摘要:
The present invention is directed to a method for detecting the presence or absence of a mutation of interest in the nucleic acid of a pathogen, wherein the mutation of interest is located adjacent to a length polymorphism defining multiple quasispecies of the pathogen.
摘要:
The present invention is directed to a method for detecting the presence or absence of a mutation of interest in the nucleic acid of a pathogen, wherein the mutation of interest is located adjacent to a length polymorphism defining multiple quasispecies of the pathogen.
摘要:
The present invention relates to methods and products for the evaluation of HIV treatment. In particular, molecular events at the HIV envelope protein and their effect on therapeutic efficacy of drugs are determined. The methods rely on providing HIV envelope nucleic acid material and evaluating a treatment either through genotyping or phenotyping. Said method may find use in multiple fields including diagnostics, drug screening, pharmacogenetics and drug development.
摘要:
An end-board is provided for supporting and handling a core-wound roll of material, such as a roll of polymer film. The end-board generally comprises a support plate comprising a product face, an outer face, a core support aperture, a core channel, and the core support aperture for supporting a core plug or a core therein. The product face comprises a roll recess for receiving an end of the core-wound roll within the roll recess when the core plug or core is positioned in the core support aperture. A locking collar may also be provided to selectively engage the support plate in the support plate core channel to prevent the supported core or core plug from passing through the core channel. A pair of handles may also be provided within the support plate to facilitate end-board manipulation.
摘要:
The present invention is directed to a method for detecting the presence or absence of a mutation of interest in the nucleic acid of a pathogen, wherein the mutation of interest is located adjacent to a length polymorphism defining multiple quasispecies of the pathogen.